Cargando…

Radiogenomics Analysis Linking Multiparametric MRI and Transcriptomics in Prostate Cancer

SIMPLE SUMMARY: Prostate cancer is a global health burden. Multi-parametric magnetic resonance imaging is the recommended imaging modality for diagnosis. The recommended treatment differs based on tumor aggressiveness, typically assessed with the use of invasive techniques such as tumor biopsies. By...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dinis Fernandes, Catarina, Schaap, Annekoos, Kant, Joan, van Houdt, Petra, Wijkstra, Hessel, Bekers, Elise, Linder, Simon, Bergman, Andries M., van der Heide, Uulke, Mischi, Massimo, Zwart, Wilbert, Eduati, Federica, Turco, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296397/ https://www.ncbi.nlm.nih.gov/pubmed/37370685 http://dx.doi.org/10.3390/cancers15123074

Ejemplares similares

The Effects of Enzalutamide Monotherapy on Multiparametric 3T MR Imaging in Prostate Cancer
por: Van der Roest, Rosanne CV., et al.
Publicado: (2016)

Multiparametric ultrasound in the detection of prostate cancer: a systematic review
por: Postema, Arnoud, et al.
Publicado: (2015)

Exploring the Onset and Progression of Prostate Cancer through a Multicellular Agent-based Model
por: Passier, Margot, et al.
Publicado: (2023)

Multiparametric dynamic contrast-enhanced ultrasound imaging of prostate cancer
por: Wildeboer, Rogier R., et al.
Publicado: (2016)

Clinical Trial Protocol: Developing an Image Classification Algorithm for Prostate Cancer Diagnosis on Three-dimensional Multiparametric Transrectal Ultrasound
por: Jager, Auke, et al.
Publicado: (2023)

Automated multiparametric localization of prostate cancer based on B-mode, shear-wave elastography, and contrast-enhanced ultrasound radiomics
por: Wildeboer, Rogier R., et al.
Publicado: (2019)

Corrigendum to “Clinical Trial Protocol: Developing an Image Classification Algorithm for Prostate Cancer Diagnosis on Three-dimensional Multiparametric Transrectal Ultrasound” [Eur. Urol. Open Sci. 49 (2023) 32–43]
por: Jager, Auke, et al.
Publicado: (2023)

Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external‐beam radiation therapy
por: Dinis Fernandes, Catarina, et al.
Publicado: (2018)

Multiparametric ultrasound: evaluation of greyscale, shear wave elastography and contrast-enhanced ultrasound for prostate cancer detection and localization in correlation to radical prostatectomy specimens
por: Mannaerts, Christophe K., et al.
Publicado: (2018)

The unique second wave phenomenon in contrast enhanced ultrasound imaging with nanobubbles
por: Chen, Chuan, et al.
Publicado: (2022)

Towards Dynamic Contrast Specific Ultrasound Tomography
por: Demi, Libertario, et al.
Publicado: (2016)

Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
por: Linder, Simon, et al.
Publicado: (2018)

Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: a Longitudinal Case-Control Study in Colon Cancer
por: Turco, Simona, et al.
Publicado: (2018)

Quantitative Magnetic Resonance Imaging for Biological Image-Guided Adaptive Radiotherapy
por: van Houdt, Petra J., et al.
Publicado: (2021)

Experimental acoustic characterization of an endoskeletal antibubble contrast agent: First results
por: Panfilova, Anastasiia, et al.
Publicado: (2021)

Radium-223 Treatment of Patients with Metastatic Castration Resistant Prostate Cancer: Biomarkers for Stratification and Response Evaluation
por: van der Zande, Kim, et al.
Publicado: (2021)

The Prognostic Potential of Human Prostate Cancer-Associated Macrophage Subtypes as Revealed by Single-Cell Transcriptomics
por: Siefert, Joseph C., et al.
Publicado: (2021)

A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer
por: Palit, Sander A. L., et al.
Publicado: (2021)

TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth
por: Palit, Sander AL, et al.
Publicado: (2019)

Radiogenomics of lung cancer
por: Wong, Chi Wah, et al.
Publicado: (2020)

Radiogenomics in Colorectal Cancer
por: Badic, Bogdan, et al.
Publicado: (2021)

MRI basics for radiation oncologists
por: van der Heide, Uulke A., et al.
Publicado: (2019)

Quantitative 3-T multi-parametric MRI and step-section pathology of recurrent prostate cancer patients after radiation therapy
por: Dinis Fernandes, Catarina, et al.
Publicado: (2018)

Novel contrast-enhanced ultrasound imaging in prostate cancer
por: Smeenge, Martijn, et al.
Publicado: (2011)

Longitudinal Correlations Between Intravoxel Incoherent Motion (IVIM) and Dynamic Contrast-Enhanced (DCE) MRI During Radiotherapy in Prostate Cancer Patients
por: Kooreman, Ernst S., et al.
Publicado: (2022)

Radiomics and radiogenomics for precision radiotherapy
por: Wu, Jia, et al.
Publicado: (2018)

Radiogenomics and Radiomics in Liver Cancers
por: Saini, Aman, et al.
Publicado: (2018)

Precision Medicine in Radiomics and Radiogenomics
por: Monti, Serena
Publicado: (2022)

Accurate validation of ultrasound imaging of prostate cancer: a review of challenges in registration of imaging and histopathology
por: Wildeboer, Rogier R., et al.
Publicado: (2018)

Optimized ChIP-seq method facilitates transcription factor profiling in human tumors
por: Singh, Abhishek A, et al.
Publicado: (2018)

Radiomics and radiogenomics of primary liver cancers
por: Jeong, Woo Kyoung, et al.
Publicado: (2019)

Breast Ultrasound Microvascular Imaging and Radiogenomics
por: Park, Ah Young, et al.
Publicado: (2021)

Reliability of whole mount radical prostatectomy histopathology as the ground truth for artificial intelligence assisted prostate imaging
por: Jager, Auke, et al.
Publicado: (2023)

Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2015)

Radiogenomics-based cancer prognosis in colorectal cancer
por: Badic, Bogdan, et al.
Publicado: (2019)

Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma
por: Kong, Doo-Sik, et al.
Publicado: (2016)

Combining molecular and imaging metrics in cancer: radiogenomics
por: Lo Gullo, Roberto, et al.
Publicado: (2020)

Radiomics and radiogenomics in gliomas: a contemporary update
por: Singh, Gagandeep, et al.
Publicado: (2021)

Contrast-enhanced ultrasound tractography for 3D vascular imaging of the prostate
por: van Sloun, Ruud J. G., et al.
Publicado: (2018)

T(1ρ) for Radiotherapy Treatment Response Monitoring in Rectal Cancer Patients: A Pilot Study
por: Kooreman, Ernst S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3nc5fes6e08t0m6epfnjc2383e